Next |
home / stock / fcsc / fcsc message board
Subject | By | Source | When |
---|---|---|---|
News: $FCSC Due to Rising Prevalence of Cancer | whytestocks | investorshub | 09/16/2019 12:40:20 PM |
.01 | CarlCarlMcB | investorshub | 07/05/2019 5:09:44 PM |
News: $FCSC Fibrocell to Present at BIO International | whytestocks | investorshub | 05/30/2019 12:40:39 PM |
News: $FCSC Fibrocell Receives FDA Regenerative Medicine Advanced | whytestocks | investorshub | 05/29/2019 3:30:38 PM |
GREEN | beambe | investorshub | 04/26/2019 8:00:37 PM |
I agree with that | beambe | investorshub | 04/26/2019 2:15:17 PM |
Added this to my list yesterday. Can't | BooDog | investorshub | 04/26/2019 10:26:57 AM |
PATIENCE | beambe | investorshub | 04/25/2019 6:32:18 PM |
Parabolic move is coming here, question is just when. | Makk1 | investorshub | 04/25/2019 10:46:48 AM |
https://www.nasdaq.com/symbol/fcsc/institutional-holdings | beambe | investorshub | 04/23/2019 5:40:18 PM |
http://fibrocell.com/pipeline-clinical-trials/ | beambe | investorshub | 04/18/2019 5:27:59 PM |
https://www.wallstreet-online.de/aktien/fibrocell-science-aktie/kurse | beambe | investorshub | 04/18/2019 5:19:41 PM |
GREEN | beambe | investorshub | 04/17/2019 8:00:56 PM |
$FCSC easy 50%. No brainer | ZIA SPIRIT | investorshub | 04/17/2019 1:53:54 PM |
Great buy here imo | ZIA SPIRIT | investorshub | 04/17/2019 1:32:58 PM |
Everything is out now. Even Form 4's. | $avvyPenny$tockInvestorâ„¢ | investorshub | 04/17/2019 12:12:49 AM |
8k and Form 4's out. | $avvyPenny$tockInvestorâ„¢ | investorshub | 04/17/2019 12:09:35 AM |
I wonder who is manipulating this? | $avvyPenny$tockInvestorâ„¢ | investorshub | 04/16/2019 8:02:34 PM |
ClayTraders said no | beambe | investorshub | 04/16/2019 7:44:40 PM |
We will be lucky to back at 2.54 | Imarket13 | investorshub | 04/16/2019 6:44:44 PM |
News, Short Squeeze, Breakout and More Instantly...
Fibrocell Science Inc. Company Name:
FCSC Stock Symbol:
NASDAQ Market:
PARSIPPANY, N.J. , Sept. 12, 2019 /PRNewswire/ -- Castle Creek Pharmaceutical Holdings, Inc. ("CCP Holdings") today announced it has reached an agreement to acquire Fibrocell Science, Inc. (Nasdaq: FCSC), a cell and gene therapy company focused on transformational autologous cell-bas...
- Total consideration of $ 63.3 million, including repayment of debt and other financial instruments - - Acquisition expected to close in the fourth quarter of 2019 - - Further strengthens Castle Creek Pharmaceuticals as a leader in dermatology - EXTON, Pa., Sept. 12, 2019 (GL...
- Company to Host Conference Call and Webcast on Thursday, August 15 at 8:30 a.m. EDT - EXTON, Pa., Aug. 14, 2019 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (Nasdaq: FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissu...